Zoetis
ZTS
#432
Rank
HK$443.50 B
Marketcap
HK$1,006
Share price
1.18%
Change (1 day)
-18.73%
Change (1 year)

Revenue for Zoetis (ZTS)

Revenue in 2024: HK$71.85 Billion

According to Zoetis's latest financial reports the company's current revenue (TTM ) is HK$73.43 Billion. In 2024 the company made a revenue of HK$71.85 Billion an increase over the revenue in the year 2023 that were of HK$66.72 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Zoetis from 2011 to 2024

Annual revenue

Year Revenue Change
2024HK$71.85 B7.69%
2023HK$66.72 B5.7%
2022HK$63.13 B4.12%
2021HK$60.63 B17.18%
2020HK$51.74 B6.14%
2019HK$48.75 B6.88%
2018HK$45.61 B10.01%
2017HK$41.46 B9.39%
2016HK$37.90 B2.63%
2015HK$36.93 B-0.49%
2014HK$37.11 B4.94%
2013HK$35.36 B5.23%
2012HK$33.60 B2.23%
2011HK$32.87 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
HK$490.66 B 568.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$464.35 B 532.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$371.39 B 405.75%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$501.98 B 583.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Phibro Animal Health
PAHC
HK$10.93 B-85.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Kindred Biosciences
KIN
HK$61.94 M-99.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Heska Corporation
HSKA
HK$1.99 B-97.29%๐Ÿ‡บ๐Ÿ‡ธ USA